| NCT ID | NCT05015452 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Helios Health Institute GmbH |
| Condition | Aortic Valve Stenosis |
| Study Type | OBSERVATIONAL |
| Enrollment | 20,000 participants |
| Start Date | 2020-03-01 |
| Primary Completion | 2030-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 20,000 participants in total. It began in 2020-03-01 with a primary completion date of 2030-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
A single-center registry including all patients treated with TAVI at the Heart Center, Leipzig, Germany
Eligibility Criteria
Inclusion Criteria: * All patients treated with TAVI Exclusion Criteria: * None
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05015452 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Aortic Valve Stenosis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05015452 currently recruiting?
Yes, NCT05015452 is actively recruiting participants. Contact the research team at mohamed.bdel-wahab@medizin.uni-leipzig.de for enrollment information.
Where is the NCT05015452 trial being conducted?
This trial is being conducted at Leipzig, Germany.
Who is sponsoring the NCT05015452 clinical trial?
NCT05015452 is sponsored by Helios Health Institute GmbH. The trial plans to enroll 20,000 participants.